The initial reporter stated they received discrepant results for one patient sample tested with elecsys ft3 iii and the elecsys ft4 iii assay on a cobas 8000 e 602 module.The initial sample values were reported outside of the laboratory.The results from the e 602 did not correlate with the patient's physical symptoms.This medwatch will apply to the ft4 assay.Patient identifier (b)(6) for information related to the ft3 assay.The sample was tested twice on the e 602 analyzer, resulting with ft3 values of 6.290 pg/ml and 6.110 pg/ml (reference range = 2.0 - 4.4 pg/ml).The sample was repeated on an abbott architect analyzer on (b)(6) 2021, resulting with a ft3 value of 1.44 pg/ml (reference range = 1.88 - 3.18 pg/ml).The sample was tested twice on the e 602 analyzer, resulting with ft4 values of 2.980 ng/dl and 2.770 ng/dl (reference range = 0.93 - 1.71 ng/dl).The sample was repeated on an abbott architect analyzer on (b)(6) 2021, resulting with a ft4 value of 0.69 ng/dl (reference range = 0.70 - 1.48 ng/dl).The serial number of the customer's e 602 analyzer is (b)(4).
|